Effect of oral anticoagulants on the outcome of faecal immunochemical test

British Journal of Cancer

Volumn 110, Issue 5, 2014, Pages 1334-1337

  Bujanda, L ^a   Sarasqueta, C ^a   Lanas, A ^b   Quintero, E ^c   Cubiella, J ^d   Hernandez, V ^e   Morillas, J D ^f   Perez Fernandez T ^g   Salas, D ^h   Andreu, M ⁱ   Carballo, F ^j   Bessa, X ⁱ   Portillo, I ^k   Jover, R ^l   Balaguer, F ^m   Cosme, A ^a   Castells, A ^m  

^a HOSPITAL DONOSTIA   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c UNIVERSIDAD DE LA LAGUNA   (Spain)

^d Department of Gastroenterology Hospital Universitario de Canarias Universidad de la Laguna ^*  (Spain)

^e UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

^f HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^g HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^h Programa de Cribado de Cáncer Colorrectal Dirección General de Salud Pública Conselleria de Sanitat   (Spain)

ⁱ INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^j HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^k Centro Coordinador del Programa de Cribado de Cáncer Colorrectal   (Spain)

^l HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^m HOSPITAL CLÍNIC   (Spain)

more..

Author keywords

Advanced neoplasia; Colorectal cancer screening; Faecal immunochemical test; FIT; Oral anticoagulant

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL;

ADULT; ADVANCED CANCER; ADVANCED NEOPLASIA; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OCCULT BLOOD; OUTCOME ASSESSMENT; PERFORMANCE; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; COLORECTAL ADENOMA;

ANTICOAGULANTS; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOCHEMISTRY; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD;

EID: 84895780690     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.38     Document Type: Article

References (10)

1. Blacker DJ, Wijdicks EF, Mc Clellland RL (2003) Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy. Neurology 61: 964-968. (Pubitemid 37248654)
2. Bujanda L, Lanas A, Quintero E, Castells A, Sarasqueta C, Cubiella J, Hernandez V, Morillas JD, Perez-Fernández T, Salas D, Andreu M, Carballo F, Bessa X, Cosme A, Jover R. COLONPREV Study Investigators (2013) Effect of aspirin and antiplatelet drugs on the outcome of fecal immunochemical test. Mayo Clin Proc 88: 683-689.
3. Dossett LA, Riesel JN, Griffin MR, Cotton BA (2011) Prevalence and implications of preinjury warfarin use. Arch Surg 146: 565-570.
4. Fraser CG, Allison JE, Halloran SP, Young GP; Expert Working Group on Fecal Immunochemical Tests for Hemoglobin; Colorectal Cancer Screening Committee; World Endoscopy Organization (2012) A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin. J Natl Cancer Inst 104: 810-814.
5. Jover R, Herráiz M, Alarcón O, Brullet E, Bujanda L, Bustamante M, Campo R, Carreño R, Castells A, Cubiella J, García-Iglesias P, Hervás AJ, Menchén P, Ono A, Panadés A, Parra-Blanco A, Pellisé M, Ponce M, Quintero E, Reñé JM, Sánchez del Río A, Seoane A, Serradesanferm A, Soriano Izquierdo A, Vázquez Sequeiros E. Spanish Society of Gastroenterology; Spanish Society of Gastrointestinal Endoscopy Working Group (2012) Clinical practice guidelines: quality of colonoscopy in colorectal cancer screening. Endoscopy 44: 444-451.
6. Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Lieberman N, Klang S, Niv Y (2009) Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs and anticoagulants. Am J Gastroenterol 104: 933-938.
7. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, Dash C, Giardiello FM, Glick S, Johnson D, Johnson CD, Levin TR, Pickhardt PJ, Rex DK, Smith RA, Thorson A, Winawer SJ; American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134: 1570-1595. (Pubitemid 351615355)
8. Mandelli G, Radaelli F, Paggi S, Terreni N, Gola G, Gramegna M, Bonaffini A, Terruzzi V (2011) Anticoagulant or aspirin treatment does not affect the positive predictive value of an immunological fecal occult blood test in patients undergoing colorectal cancer screening: results from a nested in a cohort case-control study. Eur J Gastroenterol Hepatol 23: 323-326.
9. Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas Á, Andreu M, Carballo F, Morillas JD, Hernández C, Jover R, Montalvo I, Arenas J, Laredo E, Hernández V, Iglesias F, Cid E, Zubizarreta R, Sala T, Ponce M, Andrés M, Teruel G, Peris A, Roncales MP, Polo-Tomás M, Bessa X, Ferrer-Armengou O, Grau J, Serradesanferm A, Ono A, Cruzado J, Pérez-Riquelme F, Alonso-Abreu I, de la Vega-Prieto M, Reyes-Melian JM, Cacho G, Díaz-Tasende J, Herreros-de-Tejada A, Poves C, Santander C, González-Navarro A. COLONPREV Study Investigators (2012) Colonoscopy versus fecal immunochemical test in colorectal cancer screening. N Engl J Med 366: 697-706.
10. Sawhney MS, McDougall H, Nelson DB, Bond JH (2010) Fecal occult blood test in patients on low-dose aspirin, warfarin, clopidogrel, or non-steroidal anti-inflammatory drugs. Dig Dis Sci 55: 1637-1642.